Pacira BioSciences, Inc. (PCRX) insider trading

By person

36 insiders · 361 transactions

26.7×

Frank Lee holds 26.7 times base salary in stock. $24.00M of shares against $896.54K in salary for 2024.

Salary from the company's own proxy. The shares are what Frank Lee last reported holding, valued at $36.32, the price Common Stock was last bought or sold at on the open market here, on 8 Oct 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Andreas Wicki

Director

—

$40.51M (20)

−$40.51M

2,393,165

6.00%

$86.92M

−21.3%

David M Stack

CEO and Chairman

—

$31.79M (56) scheduled

−$31.79M

302,980

0.7601%

$11.00M

+250.9%

Kristen Williams

Chief Administrative Officer

—

$14.18M (41) scheduled

−$14.18M

167,062

0.4191%

$6.07M

+967.5%

Max Reinhardt

President, Rest of World

—

$6.61M (17) scheduled

−$6.61M

29,225

0.0733%

$1.06M

+2,050%

Gary W Pace

Director

$412.97K (2)

$5.87M (6)

−$5.46M

22,127

0.0555%

$803.65K

−0.2%

Lauren Riker

Senior Vice President, Finance

—

$4.94M (49) scheduled

−$4.94M

62,284

0.1563%

$2.26M

+346.3%

Charles Anthony Laranjeira

Chief Technical Officer

—

$3.81M (12) scheduled

−$3.81M

41,752

0.1047%

$1.52M

+1,667%

Roy Winston

Chief Medical Officer

$91.25K (1)

$3.31M (19) scheduled

−$3.22M

52,440

0.1316%

$1.90M

+163.8%

James S Scibetta

President

—

$2.61M (5) scheduled

−$2.61M

25,118

0.0630%

$912.29K

−7.3%

Anthony Molloy

Chief Lgl & Compliance Officer

—

$2.36M (11) scheduled

−$2.36M

12,877

0.0323%

$467.69K

−20.5%

Richard Scranton

Chief Scientific Officer

—

$1.98M (6) scheduled

−$1.98M

16,061

0.0403%

$583.34K

+231.6%

Shawn Cross

Chief Financial Officer

—

$1.52M (7) scheduled

−$1.52M

95,801

0.2403%

$3.48M

—

Laura Brege

Director

$12.81K (1)

$1.20M (4) scheduled

−$1.19M

30,120

0.0756%

$1.09M

+1,111%

John P Phd Longenecker

Director

—

$923.42K (3) scheduled

−$923.42K

18,823

0.0472%

$683.65K

+396.9%

Paul J Hastings

Director

—

$800.68K (10) scheduled

−$800.68K

12,724

0.0319%

$462.14K

+297.0%

Jonathan Slonin

Chief Medical Officer

—

$628.00K (12) scheduled

−$628.00K

216,384

0.5428%

$7.86M

+537.0%

Dennis McLoughlin

Chief Customer Officer

—

$608.87K (7)

−$608.87K

38,115

0.0956%

$1.38M

+125.7%

Charles A. Reinhart III

Chief Financial Officer

—

$555.97K (7)

−$555.97K

51,867

0.1301%

$1.88M

—

Mark A. Kronenfeld

Director

$152.46K (4)

$555.60K (1) scheduled

−$403.14K

34,901

0.0876%

$1.27M

+686.4%

Daryl Gaugler

Chief Operating Officer

—

$327.84K (8) scheduled

−$327.84K

115,443

0.2896%

$4.19M

+784.5%

Donald C. Manning

Chief Medical Officer

—

$306.82K (2)

−$306.82K

29,520

0.0741%

$1.07M

—

Mark Froimson

Director

$19.93K (2)

$123.31K (3)

−$103.39K

26,541

0.0666%

$963.97K

—

Frank D. Lee

Chief Executive Officer

$99.99K (1)

—

+$99.99K

660,831

1.66%

$24.00M

+48,354%

Ronald J. Ellis Jr.

Chief Strategy Officer

—

$87.44K (2)

−$87.44K

30,909

0.0775%

$1.12M

−6.9%

James B Jones

SVP & Chief Medical Officer

—

$68.17K (2)

−$68.17K

16,823

0.0422%

$611.01K

+53.8%

Abraham Ceesay

Director

—

$64.01K (1) scheduled

−$64.01K

9,039

0.0227%

$328.30K

—

Marcelo Bigal

Director

$60.87K (2)

$116.27K (1)

−$55.40K

17,798

0.0446%

$646.42K

—

Scott Braunstein

Chief Operating Officer

—

$33.27K (1)

−$33.27K

20,982

0.0526%

$762.07K

+95.2%

Michael J. Yang

Director

$25.80K (1)

—

+$25.80K

19,798

0.0497%

$719.06K

—

Robert J. Weiland

Chief Commercial Officer

—

$12.32K (1)

−$12.32K

5,088

0.0128%

$184.80K

+429.4%

Brendan Teehan

Chief Commercial Officer

—

100,934

0.2532%

$3.67M

—

Christopher Christie

Director

—

23,059

0.0578%

$837.50K

—

Alethia Young

Director

—

17,798

0.0446%

$646.42K

—

Yvonne Greenstreet

Director

—

13,247

0.0332%

$481.13K

+279.8%

Dennis L Winger

Director

—

7,490

0.0188%

$272.04K

+22.1%

Samit Hirawat

Director

—

6,405

0.0161%

$232.63K

—

Pacira BioSciences, Inc.

What the insiders did Net selling

By person